351 Rouse Boulevard

351 Rouse is a core and shell design (the first phase of a micro-research campus) for Adaptimmune, a cancer research firm that studies the agitation of T-cell receptors.  The building design draws inspiration from this research, first on the exterior through the disruption of the ribbon windows at circulation nodes and secondarily at the custom-milled plywood slabs that line the monumental stair. The repetitive module of the structural precast spandrel panels has been subverted through the application of a scripted pattern that brings life and texture to these economically-driven building components. This building received a LEED gold certification.